Health Technology Collaboration
CND Biomarker Testing Services Utilizing Groundbreaking NerValence™ System Unveiled at the AD/PD™ 2024 Parkinson's and Alzheimer's Disease Conference SCOTTSDALE, Ariz.., March 5, 2024 /PRNewswire/ -- CND Life Sciences (CND), a...
Nijmegen, Netherlands – Aiosyn, a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney disease, announced the introduction of its NephroPath platform. By partnering with Aiosyn,...
Proscia: Paving the way to advance cancer research and diagnosis with enriched, high-quality DICOM images CAMBRIDGE, Mass. and PHILADELPHIA – February 27, 2024 – Proscia®, a leading provider of digital and computational pathology...
Lunit: A new study published in the Journal for ImmunoTherapy of Cancer (JITC) shows that Lunit's AI-powered biomarker "Lunit SCOPE IO" can predict favorable outcomes of Inflamed Immune Phenotype patients treated with Immune Checkpoint...
There’s a Whole Lot of Clicking Goin’ On
Unlike the song by a similar name, There's not a whole lot of loving going on, in my heart It's a feeling, I'm feeling through and through There's not a whole lot of missing every time we're apart There's not a whole lot of loving just for...
Imagene: ImageneOI is the first NSCLC genomic profiling AI tool on the Sectra Amplifier Marketplace. TEL AVIV, Israel, February 12, 2024 (Newswire.com) - Imagene, a pioneer in AI-based precision oncology, today announced the integration of...
